2880 records found.
Jan 24, 2020
Crown Aesthetics Announces Addition Of ProGen PRP(TM) Advantage To ProGen PRP Portfolio
Jan 24, 2020
BERG Presents Initial Clinical Data And Identification Of Response Biomarkers In A Phase 2 Pancreatic Cancer Trial Guided By Using The Interrogative Biology® Platform At ASCO-GI Meeting
Jan 24, 2020
Abbott Receives Expanded Indication From the U.S. FDA for Directional Deep Brain Stimulation System to Treat Parkinson's Disease
Jan 24, 2020
Shoreline Biome to Launch New DNA Isolation Kit at Miami Winter Symposium 2020
Jan 24, 2020
Dr. Seth Resnick, AdvantageCare Physicians' Chair of Psychiatry, Named Distinguished Fellow by American Psychiatric Association
Jan 24, 2020
Prader-Willi Syndrome Pipeline Study, H1 2020 - Analysis by Stage of Development, Drug Target, Mechanism of Action, Route of Administration and Molecule Type
Jan 24, 2020
Sirnaomics Advances RNAi-Based Prophylactics and Therapeutics to Battle SARI Caused by 2019-nCoV
Jan 23, 2020
Elypta Raises EUR6 Million in a Late Seed Round Led by Industrifonden
Jan 23, 2020
Digbi Health Announces Appointment of Imran Junaid, MD, as Chief Medical Officer
Jan 23, 2020
Global Cardiac Mapping Market by Product, Indication and Region - Forecast to 2024
Jan 23, 2020
Genome Medical Adds Population Genomics Offering to Enable Increased Access for Individuals Nationwide
Jan 23, 2020
AF Symposium 2020: Acutus Medical to Live-Stream Case Using First & Only System with Three Mapping Modalities
Jan 23, 2020
Starting Hearts Launches #SaveMoreLives Challenge and Partners with Presidential Daughter, Susan Ford Bales, to Help Save 100,000 Lives Per Year by 2040
Jan 23, 2020
Genetic Scanning System in Sperm May Control Rate of Human Evolution
Jan 23, 2020
Delaware, CRISPR and Cellicon Valley: A Special Event on February 6th
Jan 23, 2020
Diagnostic Electrocardiograph (ECG) Market Outlook 2019-2024 - Key Players are GE Healthcare, Philips Healthcare, Nihon Kohden, Hill-Rom, and Ambu
Jan 22, 2020
Animal Growth Promoters and Performance Enhancers Market Worth $18.5 Billion by 2024 - Exclusive Report by MarketsandMarkets(TM)
Jan 22, 2020
Akcea and Ionis report positive topline Phase 2 results of AKCEA-APOCIII-L Rx
Jan 22, 2020
Nevro to Present New Clinical Evidence at the 23rd Annual North American Neuromodulation (NANS) Society Meeting
Jan 22, 2020
Proteostasis Therapeutics Announces Keystone Symposia Presentation of Organoid Study from More than 300 Adult CF Patients

Pages